Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Design and rationale of a randomized controlled trial to reduce cardiovascular disease risk for patients with bipolar disorder.

Goodrich DE, Kilbourne AM, Lai Z, Post EP, Bowersox NW, Mezuk B, Schumacher K, Bramlet M, Welsh DE, Bauer MS. Design and rationale of a randomized controlled trial to reduce cardiovascular disease risk for patients with bipolar disorder. Contemp Clin Trials. 2012 Jul; 33(4):666-78.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.